{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:00:57Z","timestamp":1793876457617,"version":"4.7.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.phrs.2025.107759","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T10:46:51Z","timestamp":1746355611000},"page":"107759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5099-3790","authenticated-orcid":false,"given":"Celestino","family":"Sardu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Consiglia","family":"Trotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica Vittoria","family":"Marfella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"La Marca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Turriziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Rafaniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando Carlo","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Marfella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2137-455X","authenticated-orcid":false,"given":"Giuseppe","family":"Paolisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.phrs.2025.107759_bib1","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.phrs.2025.107759_bib2","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.phrs.2025.107759_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12933-017-0554-2","article-title":"Multipolar pacing by cardiac resynchronization therapy with defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes","volume":"16","author":"Sardu","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107759_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jdi.12042","article-title":"Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease","volume":"4","author":"Vinik","year":"2013","journal-title":"J. Diabetes Invest."},{"issue":"14","key":"10.1016\/j.phrs.2025.107759_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006558","article-title":"Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome","volume":"96","author":"Sardu","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.phrs.2025.107759_bib6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12933-024-02312-0","article-title":"The potential anti-arrhythmic effect of SGLT2 inhibitors","volume":"23","author":"Duan","year":"2024","journal-title":"Cardiovasc Diabetol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107759_bib7","first-page":"546","article-title":"The serendipitous story of SGLT2 inhibitors in heart failure","volume":"123","author":"Verma","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2025.107759_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155243","article-title":"SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study","volume":"137","author":"Sardu","year":"2022","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.phrs.2025.107759_bib9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12933-024-02312-0","article-title":"The potential anti-arrhythmic effect of SGLT2 inhibitors","volume":"23","author":"Duan","year":"2024","journal-title":"Cardiovasc Diabetol."},{"issue":"35","key":"10.1016\/j.phrs.2025.107759_bib10","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"ESC Scientific Document Group. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur. Heart J."},{"issue":"37","key":"10.1016\/j.phrs.2025.107759_bib11","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"ESC Scientific Document Group. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.phrs.2025.107759_bib12","first-page":"9","article-title":"Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an ICD","volume":"23","author":"Node","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2025.107759_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2016.10.017","article-title":"The na(+)-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer","volume":"170","author":"Koepsell","year":"2017","journal-title":"Pharm. Ther."},{"issue":"15","key":"10.1016\/j.phrs.2025.107759_bib14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Empagliflozin in patients with heart failure and reduced ejection fraction","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.phrs.2025.107759_bib15","first-page":"632","article-title":"Mechanisms of cardiovascular benefits of sodium glucose cotransporter 2 (SGLT2) inhibitors","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"A State---Art. Rev. JACC Basic Transl. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107759_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12933-024-02312-0","article-title":"The potential anti-arrhythmic effect of SGLT2 inhibitors","volume":"23","author":"Duan","year":"2024","journal-title":"Cardiovasc Diabetol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107759_bib17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.hrthm.2008.04.013","article-title":"HRS\/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices","volume":"5","author":"Wilkoff","year":"2008","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.phrs.2025.107759_bib18","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/dom.14854","article-title":"Incident heart failure, arrhythmias and cardiovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: insights from a global federated electronic medical record database","volume":"25","author":"Fawzy","year":"2023","journal-title":"Diabetes Obes. Metab."},{"issue":"36","key":"10.1016\/j.phrs.2025.107759_bib19","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/eurheartj\/ehab560","article-title":"Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF","volume":"42","author":"Curtain","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2025.107759_bib20","first-page":"1357","article-title":"Inappropriate implantable cardioverter-defibrillator shocks in MADIT II","volume":"51","author":"Daubert","year":"2008","journal-title":"Freq., Mech., Predict., Surviv. Impact J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107759_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.001359","article-title":"Molecular mechanisms of sympathetic remodeling and arrhythmias","volume":"9","author":"Gardner","year":"2016","journal-title":"Circ. Arrhythm. Electro"},{"key":"10.1016\/j.phrs.2025.107759_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106243","article-title":"The impact of SGLT2 inhibition on imaging markers of cardiac function: a systematic review and meta-analysis","volume":"180","author":"Theofilis","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2025.107759_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","article-title":"Effects of SGLT2 inhibitors on kidney and cardiovascular function","volume":"83","author":"Vallon","year":"2021","journal-title":"Annu Rev. Physiol."},{"key":"10.1016\/j.phrs.2025.107759_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106303","article-title":"Angiotensin receptor\/Neprilysin inhibitor effects in CRTd non-responders: from epigenetic to clinical beside","volume":"182","author":"Sardu","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2025.107759_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106448","article-title":"Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes","volume":"184","author":"Marfella","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2025.107759_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2022.03.005","article-title":"Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: evidence for potential off-target effects","volume":"167","author":"Dyck","year":"2022","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.phrs.2025.107759_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101549","article-title":"Cardiovascular protection by SGLT2 inhibitors - Do anti-inflammatory mechanisms play a role?","volume":"64","author":"Elrakaybi","year":"2022","journal-title":"Mol. Metab."},{"issue":"4","key":"10.1016\/j.phrs.2025.107759_bib28","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.hrthm.2015.12.024","article-title":"Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT","volume":"13","author":"Medina","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.phrs.2025.107759_bib29","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fphys.2018.00758","article-title":"Stretch, injury and inflammation markers evaluation to predict clinical outcomes after implantable cardioverter defibrillator therapy in heart failure patients with metabolic syndrome","volume":"9","author":"Sardu","year":"2018","journal-title":"Front Physiol."},{"key":"10.1016\/j.phrs.2025.107759_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2023.04.002","article-title":"The effect of sodium-glucose cotransporter-2 inhibitors on cardiac structure remodeling and function: a meta-analysis of randomized controlled trials","volume":"114","author":"Fan","year":"2023","journal-title":"Eur. J. Intern Med"},{"issue":"3","key":"10.1016\/j.phrs.2025.107759_bib31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825001847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825001847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T22:47:18Z","timestamp":1750200438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825001847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":31,"alternative-id":["S1043661825001847"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107759","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107759"}}